The trials, which will begin in 2020, are part of a sweeping, five-year, $42 million federal research program known as Implementing Genomics in Practice. The first trial will examine whether early access to patients’ genomic data can help with treatment of high blood pressure, hypertension and chronic kidney disease.
Indianapolis-based Anthem said its purchase of Beacon Health Options fits with its strategy of diversifying into providing health care services, including for patients with complex and chronic conditions.
It’s the second approved use for Emgality, which first won U.S. approval last fall to treat migraines. Analysts predict it could become a blockbuster.
A federal judge grilled an attorney for the state of Indiana on Monday over whether the Legislature had legitimate reasons for approving a law that would largely ban a second-trimester abortion procedure.
After one of its largest listed drug makers was found to have overstated its cash position by $4.3 billion, China is starting an audit of 77 major pharmaceutical companies.
The Indianapolis-based health system said the move will give patients more treatment options. It has opened five tiny hospitals in the last two years, and plans to open three more later this year.
To recognize the contribution, Eskenazi Health is changing the name of Midtown Community Mental Health to the Sandra Eskenazi Mental Health Center.
The medical field’s lofty dreams of unleashing the power of artificial intelligence to transform medicine have yet to materialize in a major way.
Wearable devices have applications beyond people. We’re at a turning point in animal health where better data combined with innovative medicines is leading to better care for our pets.
The fast-acting insulin, which diabetics inject shortly before each meal, is used by about 700,000 Americans.
The Indiana Family & Social Services Administration says the plan is designed to help bridge the transition from the Healthy Indiana Plan to private health insurance, and help pay for premiums, deductibles, co-pays and other costs.
Indiana will recognize nursing licenses from most other states with a new law taking effect this summer.
President Donald Trump will begin a push Thursday to fight health care sticker shock by limiting the unexpected charges faced by insured patients when a member of a health care team that treated them is not in their insurer’s network.
The Trump administration has finalized regulations that will require drug companies to disclose list prices of medications costing more than $35 for a month’s supply.
A pharmaceutical company founder accused of paying doctors millions in bribes to prescribe a highly addictive fentanyl spray was convicted Thursday in a case that exposed such marketing tactics as using a stripper-turned-sales-rep to give a physician a lap dance.
Taking a harder line on health care, the Trump administration joined a coalition of Republican-led states Wednesday in asking a federal appeals court to entirely overturn former President Barack Obama's signature health care law.
Adopting universal health coverage “would significantly increase government spending and require substantial additional government resources,” the office said.
Caprice R. Bearden, the company’s former compliance officer, pleaded guilty in November to multiple criminal charges related to the sale of over-potent drugs. She later testified against her boss, who was convicted and awaits sentencing.
Indianapolis-based Lilly reported first quarter revenue of $5.09 billion, up 3% from a year ago but below analyst expectations of $5.2 billion. Sales of several of Lilly’s top drugs missed expectations.
Hospitals and patients have sued to block a new nationwide liver transplant policy that they say will waste viable livers, lead to fewer transplants and likely cause deaths.
